Senior strategy officer in the industry with more than 25 years of ample experience in regulatory matters and medicine development at Baxter and Baxalta. Tested and true trajectory building and leading high performance teams. Ample business and career experience in the main therapeutic areas with deep knowledge of global development pathways. Wide experience in types of products, including medical, biological, vaccines, biosimilars and medical devices. History of global approval of important therapeutic products: Adynovate, Obizur, Rixubis, Advate (Hemofilia), Oncaspar (Oncología), HyQvia, Kiovig, Flexbumin (Inmunología), Vepacel, Preflucel.
Paloma de Miguel
29 July, 2019
